277 related articles for article (PubMed ID: 7537395)
1. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
[TBL] [Abstract][Full Text] [Related]
2. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
[No Abstract] [Full Text] [Related]
3. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
[No Abstract] [Full Text] [Related]
4. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses.
Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF
Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558
[TBL] [Abstract][Full Text] [Related]
6. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
7. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
Cary N; Moody J; Yannoutsos N; Wallwork J; White D
Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
[No Abstract] [Full Text] [Related]
8. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
9. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
Chen RH; Kadner A; Mitchell RN; Adams DH
J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
[TBL] [Abstract][Full Text] [Related]
11. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
12. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
Kagan D; Platt J; Logan J; Byrne GW
Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
[No Abstract] [Full Text] [Related]
13. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
14. The control of hyperacute rejection by genetic engineering of the donor species.
White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
[TBL] [Abstract][Full Text] [Related]
15. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
[TBL] [Abstract][Full Text] [Related]
16. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
[TBL] [Abstract][Full Text] [Related]
17. Human decay-accelerating factor expressed on rat hearts inhibits leukocyte adhesion.
Verbakel CA; van Duikeren S; de Bruin RW; Marquet RL; IJzermans JN
Transpl Int; 2003 Mar; 16(3):168-72. PubMed ID: 12664211
[TBL] [Abstract][Full Text] [Related]
18. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
[No Abstract] [Full Text] [Related]
19. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
[No Abstract] [Full Text] [Related]
20. Life-supporting pig-to-baboon heart xenotransplantation.
Waterworth PD; Dunning J; Tolan M; Cozzi E; Langford G; Chavez G; White D; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1201-7. PubMed ID: 9883761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
